Advertisement
Dr. Smeets joins VNUS with over 17 years of clinical experience. Prior tojoining VNUS, Dr. Smeets served as the Head of Clinical Affairs for PelikanTechnologies, Inc., a privately held diagnostic testing platform company.Prior to joining Pelikan Technologies, he was Vice President of ClinicalDevelopment for Ilypsa, Inc. and Vice President of Clinical Development forGMP Companies, Inc. Dr. Smeets held increasingly responsible positions inClinical Research at Mallinckrodt BV and Mallinckrodt, Inc., as well as inSales and Marketing at Johnson & Johnson and Mallinckrodt BV. Dr. Smeetsholds a Doctor of Medicine from Utrecht University, School of Medicine, TheNetherlands and an MBA from Erasmus University, Rotterdam School ofManagement, The Netherlands.
Advertisement
VNUS President & Chief Executive Officer Brian Farley stated, "Dr. Smeetsbrings a tremendous amount of pre-clinical, clinical development and devicecommercialization experience to our company with his prior responsibilities inclinical research and sales in the medical device and pharmaceutical fields.These skills make him a highly welcome addition to the VNUS organization andSenior Management Team."
About VNUS Medical Technologies, Inc.
VNUS is a leading provider of medical devices for the minimally invasivetreatment of venous reflux, a progressive condition caused by incompetent veinvalves in the leg. VNUS sells the Closure system, which consists of aproprietary radiofrequency (RF) generator and proprietary disposableendovenous catheters and devices to treat diseased veins through theapplication of temperature-controlled RF energy. For more information, pleasevisit the corporate website at http://www.vnus.com.
SOURCE VNUS Medical Technologies, Inc.